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Abstract
Background: Ear, nose and throat involvement in granulomatosis with polyangiitis (GPA) is frequently the initial
disease manifestation. Previous investigations have observed a higher prevalence of Staphylococcus aureus in
patients with GPA, and chronic nasal carriage has been linked with an increased risk of disease relapse. In this cross-
sectional study, we investigated changes in the nasal microbiota including a detailed analysis of Staphylococcus spp.
by shotgun metagenomics in patients with active and inactive granulomatosis with polyangiitis (GPA). Shotgun
metagenomic sequence data were also used to identify protein-encoding genes within the SEED database, and the
abundance of proteins then correlated with the presence of bacterial species on an annotated heatmap.
Results: The presence of S. aureus in the nose as assessed by culture was more frequently detected in patients
with active GPA (66.7%) compared with inactive GPA (34.1%). Beta diversity analysis of nasal microbiota by bacterial
16S rRNA profiling revealed a different composition between GPA patients and healthy controls (P = 0.039). Beta
diversity analysis of shotgun metagenomic sequence data for Staphylococcus spp. revealed a different composition
between active GPA patients and healthy controls and disease controls (P = 0.0007 and P = 0.0023, respectively), and
between healthy controls and inactive GPA patients and household controls (P = 0.0168 and P = 0.0168,
respectively). Patients with active GPA had a higher abundance of S. aureus, mirroring the culture data, while
healthy controls had a higher abundance of S. epidermidis. Staphylococcus pseudintermedius, generally assumed to
be a pathogen of cats and dogs, showed an abundance of 13% among the Staphylococcus spp. in our cohort.
During long-term follow-up of patients with inactive GPA at baseline, a higher S. aureus abundance was not
associated with an increased relapse risk. Functional analyses identified ten SEED protein subsystems that differed
between the groups. Most significant associations were related to chorismate synthesis and involved in the vitamin
B12 pathway.
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Conclusion: Our data revealed a distinct dysbiosis of the nasal microbiota in GPA patients compared with disease
and healthy controls. Metagenomic sequencing demonstrated that this dysbiosis in active GPA patients is
manifested by increased abundance of S. aureus and a depletion of S. epidermidis, further demonstrating the
antagonist relationships between these species. SEED functional protein subsystem analysis identified an association
between the unique bacterial nasal microbiota clusters seen mainly in GPA patients and an elevated abundance of
genes associated with chorismate synthesis and vitamin B12 pathways. Further studies are required to further
elucidate the relationship between the biosynthesis genes and the associated bacterial species.
Keywords: GPA, Microbiome, ANCA, Vasculitis, Staphylococcus, rRNA sequencing, Metagenomics
Background
Granulomatosis with polyangiitis (GPA, formerly Wege-
ner’s granulomatosis) is a multi-system autoimmune dis-
order. Disease aetiopathogenesis is considered to be
multi-factorial but includes a host genetic component,
epigenetic modifications and the environment [1, 2],
with an increased risk of developing GPA in farmers or
those with a high occupational solvent exposure in the
index year or during their working lifetime [3]. Other
studies have demonstrated an association with dust ex-
posure, and a correlation between lifetime exposure to
high doses of silica and anti-neutrophil cytoplasm anti-
body (ANCA) positivity [4, 5].
Patients with GPA have a higher rate of nasal colonisa-
tion by Staphylococcus aureus (60–70%) than the general
population (20–30%), and the presence of persistent car-
riage has been associated with an increased risk of dis-
ease relapse during follow-up [6, 7]. A randomised
controlled trial showed a reduction of relapses following
daily administration of trimethoprim-sulfamethoxazole
(TMP-SMX) administered over a 2 -year period [8].
These findings suggest that GPA patients have a per-
turbed nasal microbiota, which may be related or con-
tribute to the high S. aureus colonisation rate.
In this study, we aimed to investigate the nasal micro-
biota in GPA patients by microbiome analysis of nasal
swabs obtained from GPA patients in an active and in-
active disease state and controls (disease controls,
healthy household controls and healthy hospital
personnel). In addition, shotgun metagenomic sequences
were used to identify differences in functional SEED pro-
tein subsystems between the sample groups and their as-
sociation with the most abundant species.
Results
Cohort and sampling
A case-control study was conducted, including 12 active
GPA patients (aGPA), 44 inactive GPA patients (inGPA),
and 13 disease controls (DC) (three with microscopic po-
lyangiitis and 10 with eosinophilic GPA). The healthy con-
trol group comprised four healthy household controls
(HHC) related to patients with aGPA (spouse or partner)
and 11 unrelated healthy controls (HC) (hospital em-
ployees). The average age across all 84 participants was
55.4 years (17–87). Detailed clinical data for the patients
and controls is given in Table 1. A total of 97 nasal swabs
were collected from 56 patients with a history of active
ear, nose and throat (ENT) involvement (12 being active
during sampling), from 13DC and from 15 healthy con-
trols. Follow-up swabs were obtained from 12 patients to
investigate temporal changes, including five swabs of pa-
tients initially classified as aGPA after remission was
achieved a month later. The residual samples were ob-
tained from patients with inGPA and one HHC.
Staphylococcus spp. culture
Bilateral nasal swabs were taken and plated onto culture
media that was selective for S. aureus. Twenty-nine sub-
jects (34.5%) were positive for S. aureus (aGPA 8/12
[66.7%], inGPA 15/44 [34.1%], DC 3/13 [23.1%], HC 2/
11 [18.2%] and HHC 1/4 [25%]).
We next sought to investigate the S. aureus isolates by
antimicrobial susceptibly testing, since a high frequency
of TMP-SMX and ciprofloxacin resistance in S. aureus
obtained from GPA patients was recently reported [9].
None of the S. aureus isolates were methicillin resistant
(MRSA), and three isolates were completely susceptible
to all antibiotics tested (Additional file 6: Table S1).
Phenotypic resistance to benzylpenicillin (n = 22, 75.9%),
erythromycin (n = 7, 24.1%) and mupirocin (n = 4,
13.8%) was common, with small numbers of isolates
exhibiting resistance to ciprofloxacin (n = 1, 3.4%), fusi-
dic acid (n = 2, 6.9%), tetracycline (n = 2, 6.9%) and tri-
methoprim (n = 1, 3.4%) (Additional file 6: Table S1).
To further investigate the S. aureus isolates, we sub-
jected the 32 isolates (8 aGPA, 15 inGPA, 1 HHC, 2 HC
and 3 DC, 3 longitudinal samples) to whole genome se-
quencing (WGS) (Table 2). Elucidation of multilocus se-
quence types (MLST) from the WGS data identified that
there were 18 unique sequence types (STs) (Add-
itional file 7: Table S2) with only three STs being found
in more than one GPA patients, namely ST45 (n = 4),
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ST15 (n = 3) and ST398 (n = 2). Generation of core
genome-based phylogenies revealed that in both GPA
patients with sequential samples the same closely related
strain was present at both time points (patients 63
(ST425) and 21 (ST398) (Additional file 1: Fig. S1). Indi-
vidual phylogenies for each of the three STs (ST398,
ST45 and ST15) revealed that all isolates from the GPA
patients were distantly related (> 100 single nucleotide
polymorphisms SNPs—S. aureus isolates that are < 50
SNPs apart are regarded as suggestive of recent trans-
mission) [10], suggesting that none of these clusters
were recent transmission events between GPA patients.
The only likely transmission event was between GPA pa-
tient 21 and their HHC partner (P23 in Additional file 1:
Fig. 1a), since their two pairs of isolates only differed by
~ 20 SNP. Analysis of the genome content revealed that
four isolates, from four different STs (STs 30, 34, 39 and
3804) were positive for the toxic shock toxin gene (tst),
which has been implicated previously in GPA relapse
[11]. Three of these were in active GPA disease (patients
33, 51 and 125) at the time of sampling, and the fourth
was from an inactive GPA case (patient 121), who subse-
quently relapsed 11 months later. None of the HC or
DC were positive for a tst positive isolate (Add-
itional file 7: Table S2).
Bacterial 16S rRNA marker gene analysis
Next, we investigated the composition of the nasal
microbiota in GPA patients in comparison to DC and
HC. Bacterial 16S sequence data was generated for 59
samples (7 aGPA, 31 inGPA, 2 DC, 7 HC, 4 HHC and 8
longitudinal including aGPA, inGPA and HHC cases).
The 16S sequences were used for oligotyping, which
generates closely related bacterial clusters called oligo-
types. A total of 64 oligotype (OTP) species were identi-
fied which were then used for heatmap analysis and
calculation of species abundance in the individual sam-
ples (Fig. 1). Hierarchical clustering as part of the heat-
map analysis identified three main clusters based on
dominant species, with clusters 2 and 3 both having dis-
tinct sub-clusters (Fig. 1a). Cluster 1 was made up of
samples from GPA patients and one HHC, which was
Table 1 Clinical characteristic of patients and controls
Participant characteristics Total subjects Active GPA (aGPA) Inactive GPA (inGPA)a Disease controls:
microscopic polyangiitis
(MPA) and eosinophilic
GPA (EGPA)
Healthy
controls (HC)
Healthy household
controls (HHC)
84 12 44 13 11 4
Age (years) 57.9 (17–73) 56.1
(42–73)
58.2
(17–87)
58.4
(42–76)
39.4 (23–58)
Gender female 46.30% 50% 47.60% 38.50% 81.80% 50%
Gender male 53.70% 50% 52.40% 61.50% 18.20% 50%
Disease duration (months) 113.3 78 124.7 110.8
BVAS WG 1.1 3.5 0.7 0.2
VDI 2.0 2.1 1.5 3.5
DEI 1.5 3.7 1.2 0.4
Steroids 56.7% 75% 47.6% 69.2%
Immunosuppressionb 59.7% 75% 57.1% 53.8%
CRP (mg/dl) 7.6 14.2 7.4 2.2
ESR (mm/h) 13.4 24.1 11 10.3
eGFR (MDRD) 87.2 83.8 87.3 90.3
Epistaxis 19.4% 83.3% 4.8% 7.7%
Mucopurulent discharge 23.9% 100% 9.5% 0%
Olfaction 19.4% 50% 7.1% 30.8%
Crusting 37.3% 75% 38.1% 0%
Inflammation 24.2% 100% 10.5% 0%
Bloody discharge 16.1% 90.9% 0% 0%
Nasal obstruction 16.1% 63.6% 7.9% 0%
Abbreviations: BVAS WG Birmingham Vasculitis Activity Score for Wegener’s Granulomatosis (WG, GPA), VDI Vasculitis Damage Index, DEI Disease Extent Index, CRP
C-reactive protein, ESR erythrocyte sedimentation rate, eGFR estimated glomerular filtration rate, MDRD Modification of Diet in Renal Disease
aInactive ear, nose and throat (ENT) GPA
bWithin the year of sample collection
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dominated by S. aureus. Cluster 2 contained samples
from all five patient groups and was dominated by S.
aureus and S. epidermidis. However, individual sub-
clusters were dominated by other species, such as cluster
2.a, which was dominated by S. pseudintermedius,
though three of four samples were from a single inGPA
patient (patient 45). Cluster 3 did not contain active
GPA patients and was characterised by two sub clusters;
cluster 3.a was dominated by Corynebacterium propin-
quum, and cluster 3.b was more diverse and dominated
by Dolosigranulum pigrum, Corynebacterium pseudo-
diphtheriticum, Corynebacterium accolens and Entero-
bacter aerogenes in one case. Notably, S. aureus and S.
epidermidis were the least common species in cluster 3.
Samples from patients on antibiotic treatment (denoted
AB in Fig. 1) were detected in all clusters.
We then examined inter-individual variability in microbial
profiles of first time point samples using a non-metric multi-
dimensional scaling (NMDS) plot (Additional file 2: Figure
S2). NMDS represents the original position of data (sam-
ples) in multidimensional space as accurately as possible
using a reduced number of dimensions that can be easily
plotted and visualised. NMDS revealed that the microbiome
in the samples from HC group clustered furthest away from
the aGPA and inGPA patients (Additional file 2: Figure
S2a). Statistical testing of this clustering using a permuta-
tional analysis of variance (PERMANOVA) test revealed that
the microbiome composition (beta diversity) between the
five groups did not differ (P > 0.05). However, when GPA
patients (aGPA and inGPA) were grouped together (GPA in
Additional file 1: Figure S2b), the microbiome cluster was
statistically different to the HC cluster (PERMANOVA test:
P= 0.039, F= 1.739), demonstrating that patients with GPA
had a distinct nasal microbiota compared with HC. We next
questioned whether patients in the inGPA group with a high
relative S. aureus abundance had a higher relapse rate dur-
ing follow-up. In the 16S sequenced group, patients with a
relapsing disease course (n= 16) had a relative mean abun-
dance of 30.14, while those with a non-relapsing course
(n= 15) had amean abundance of 22.82 (see Additional file 8:
Table S3). Unpaired t test revealed no statistical association
between S. aureus mean abundance and disease outcome (P
value, unpaired t test = 0.5739).
We further tested whether any of the top 1% species
presented in Fig. 1 showed an association with any of
the five sample groups. None of the top 1% species were
statistically different in any of the five sample groups.
To further understand the perturbations in the nasal
microbiota of GPA, we examined longitudinal changes in
the nasal microbiome in a subset of six patients for whom
we had time course samples, together with HHC in two
cases (Additional file 3: Figure S3). Bacterial 16S rRNA
gene profiles were clearly distinct between the individual
case studies, while the individual cases retained a broadly
consistent profile at the different time points. The two
HHC displayed a similar microbiome profile to their GPA
household partner, though with some obvious differences.
Shotgun sequence analysis of the nasal microbiome
We further investigated the nasal microbiome using shotgun
metagenomic sequencing. This aimed to acquire deep se-
quence information in addition to bacterial 16S sequences.
Table 2 Patient samples used for sequencing and MALDI TOF
Samples Total aGPA inGPA DC HC HHC Longitudinal
V1 V2 16Sa 59 7 31 2 7 4 (3 patients) 8 (7 patients)
Shotgun sequenced 96 12 43 13 11 5 (4 patients) 12 (11 patients)
MALDI-TOF 83 10 36 12 0 3 9
Cultured S. aureus 32 8 15 3 2 1 2
Cultured S. warneri 15 1 4 5 2 1 2
Cultured S. pasteuri 3 0 3 0 0 0 0
Cultured S. capitis 11 1 5 3 2 0 0
Cultured S. epidermidis 13 0 7 1 3 1 1
Cultured S. pseudintermedius 4 0 2 0 0 0 2 (1 patient)
Cultured S. haemolyticus 17 0 8 4 2 1 2
Cultured S. caprae 1 1 0 0 0 0 0
Cultured S. saphrophyticus 1 0 1 0 0 0 0
Cultured S. lugdunensis 2 0 1 0 1 0 0
Cultured S. simulans 1 0 0 1 0 0 0
Cultured S. pettenkoferi 1 0 0 0 1 0 0
Abbreviations: aGPA active granulomatosis with polyangiitis, inGPA inactive GPA, DC disease controls (microscopic polyangiitis and eosinophilic GPA), HC healthy
controls, HHC healthy household controls, MALDI-TOF matrix-assisted laser desorption/ionisation–time-of-flight mass spectrometry
aFor the bacterial 16S rRNA sequencing project, we sequenced the bacterial 16S rRNA variable region v1 and v2
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Ninety-six samples across all recruited patients and controls
were available (Table 2). MEGAN identified unique hits to a
total of 424 bacterial taxa with a minimum hit abundance of
0.01% which covers 96.4% of all MEGAN hits. The
Staphylococcus taxa made up 20.4% of all MEGAN hits. We
focused on the retrieved Staphylococcus taxa since it was the
most abundant taxa in the shotgun metagenomic sequences
and is commonly reported to be implicated in GPA. Import-
antly, we have previously shown that metagenomic analysis
of low-biomass samples is plagued by reagent contamination
[12]. Crucially, Staphylococcus taxa provided reliable results
without evidence of contamination in the contamination
controls. A total of 198 different Staphylococcus hits were
extracted from the shotgun sequence analysis with a
minimum abundance of 0.001% and a maximum abundance
of 32.1%. Seven Staphylococcus species were in the mini-
mum 1% abundance group which covered 88.61% of all
Staphylococcus hits in MEGAN. Thirty-two species were in
the minimum 0.1% abundance group, which covered
97.49% of all Staphylococcus hits in MEGAN (Add-
itional file 9: Table S4).
Shotgun-sequenced Staphylococcus species were ana-
lysed in the same way as bacterial 16S sequence data. For
easier presentation of the heatmap, we removed species
with less than 5% as their maximum relative abundance in
less than five samples leaving top 20 species (Fig. 2). The
hierarchical clustering (grouping of Staphylococcus spe-
cies) seen in the heatmap revealed two main clusters.
Cluster one (all sample groups except HHC samples) was
dominated by S. epidermidis together with a small propor-
tion of S. aureus in sub cluster 1a and a larger proportion
of S. aureus in sub cluster 1b. We subdivided cluster two
into four sub-clusters, whereby cluster 2a was the most di-
verse cluster with six samples. Cluster 2b was dominated
Fig. 1 Hierarchical clustering and taxonomic annotation of bacterial 16S rRNA marker gene sequenced species. Bacterial 16S sequence data were
available from 59 samples including seven active GPA, 31 inactive GPA, two disease controls (EGPA), seven unrelated healthy controls, four
healthy household controls, and eight longitudinal samples. a Hierarchical clustering with heatmap presentation was done with R package
Heatplus (v 2.20.0, Author: Alexander Ploner). For the heatmap presentation, we removed species with less than 5 % as their maximum relative
abundance in five samples which resulted in the inclusion of 34 oligotype species. b A stacked bar chart showing the distribution of the top 14
species (minimum abundance of 1% covering 93.16% of all reads) is placed next to the heatmap. c A stacked bar chart showing the distribution
of the next top 17 species (minimum abundance between 0.1% and 1% covering 5.56% of all reads)
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by S. pseudintermedius. No HC samples were found in
clusters 2a and 2b. Cluster 2c was dominated by S. aureus
and cluster 2d was dominated by S. aureus, S. epidermidis
and S. pseudintermedius. Cluster 2d contained the largest
proportion of aGPA patients.
We examined inter-individual variability in
Staphylococcus spp. profiles using NMDS and corres-
pondence analysis (CA) (Fig. 3a). NMDS and CA to-
gether with PERMANOVA testing revealed that the
overall group difference was different (PERMANOVA
test: P = 0.0031, F = 2.668). Individual group compari-
son revealed that the aGPA patients were different to
the HC (P = 0.0007, F = 8.177) and DC (P = 0.0023,
F = 4.683). In addition, the HC were different to the
inGPA patients (P = 0.0168, F = 3.82) and HHC (P =
0.0168, F = 4.755). NMDS and CA indicated that the
DC was similar to HC compared with the GPA
patients. The top seven nasal Staphylococcus species
which were in the top 1% abundance group
(Additional file 9: Table S4) were further analysed in
detail using scatter dot plot presentation together
with a Kruskal-Wallis test. S. epidermidis (32.9%
abundance) was detected at statistically higher abun-
dance in HC compared with aGPA patients (Fig. 3b).
In contrast, S. aureus (29.71% abundance) was de-
tected at statistically higher abundance in aGPA pa-
tients compared with DC and HC but was not
different to inGPA patients (Fig. 3b). Figure 3c dem-
onstrates the direction of association of S. epidermi-
dis and S. aureus in the five sample groups. In line
with results obtained from 16S rRNA analysis, no as-
sociation with relapsing disease course in those with
a high S. aureus abundance (P value, Mann-Whitney
test = 0.3581) was observed.
We examined longitudinal changes in the nasal Staphylo-
coccus profile in a subset of 13 patients with sequential
samples. Figure 4 demonstrates that the overall compos-
ition of Staphylococcus species from the initial samples
Fig. 2 Hierarchical clustering and taxonomic annotation of shotgun-sequenced Staphylococcus species. For the heatmap analysis, we removed
species with less than 5% as their maximum relative abundance in five samples, which retained 20 species for easier presentation in the heatmap.
The same 20 species were used for the stacked bar chart. Left over black bars represent other species not present in the top 20 species
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remained similar over time. However, the relative propor-
tion of species changed in some participants (e.g. 057_
aGPA or 031_inGPA), while in other participants, it
remained similar (e.g. 021_aGPA or 025_inGPA). Overall,
HHC samples showed similar Staphylococcus composition
compared with their GPA-affected spouses/partners.
Metagenomic functional profiling
We next sought to gain further insights into the nasal
microbiome dysbiosis of patients with GPA by perform-
ing functional profiling of the metagenomic data, in
order to identify genes and pathways that were signifi-
cantly different between the groups. For the functional
Figure 3 Differences in nasal Staphylococcus species composition between sample groups. a Differences in shotgun-sequenced nasal
Staphylococcus species composition between sample groups were visualised using non-metric multi-dimensional scaling (NMDS plot) and
correspondence analysis (CA plot). The significance of the separation between the different sample groups was further assessed by PERMANOVA
test (statistical test for bacterial beta diversity). The overall group comparison was statistically different (P = 0.0031). The individual group
comparisons revealed statistical differences in beta diversity between aGPA patients and HC (P = 0.0007) and between aGPA patients and disease
controls (P = 0.0023). Beta diversity was also statistically different between the HC and inGPA patients (P = 0.0168) and between HC and HHC (P =
0.0168). b Scatter dot plot presentation of statistically associated S. epidermidis and S. aureus. S. epidermidis was found at statistically higher
abundance in the HC group compared with aGPA patients. S. aureus was found at statistically higher abundance in aGPA patients compare to DC
patients and the HC groups. c The direction of the Spearman’s correlation coefficient value (positive or negative value on the y-axis) determines
whether S. epidermidis and S. aureus are either positively or negatively associated with the different sample groups. aGPA, active granulomatosis
with polyangiitis (GPA); inGPA, inactive GPA; DC, disease controls (eosinophilic GPA and microscopic polyangiitis); HC, unrelated healthy controls;
HHC, healthy household controls; PERMANOVA, permutational multivariate analysis of variance
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profiling, we used the SEED protein database analysis in
MEGAN. At level 1 SEED classification, a total of 43
subsystems were identified which were considered too
shallow, and hence we conducted a level two classifica-
tion. SEED classification has three levels, and level one
classification is the most basic classification comparable
to phylum level speciation in bacteria. The proteins an-
notated at level two classification identified 971 subsys-
tems. Out of the 971 subsystems, 319 had a minimum
abundance of 0.1% across all samples which covered
82.52% of all SEED hits in MEGAN. These 319 subsys-
tems were used for downstream statistical analysis using
the non-parametric Kruskal-Wallis test. The 319 SEED
classifications are shown in Additional file 10: Table S5.
Ten SEED functions were identified to be statistically
different within the four groups. These ten functions had
a Kruskal-Wallis test FDR-corrected P value between
0.0046 and 0.0432. Dunn’s multiple comparison test re-
vealed that these ten functions were differently associated
within the four groups (Fig. 5). For the SEED functional
Fig. 4 Taxonomic annotation of longitudinal case studies of shotgun-sequenced Staphylococcus species. Shotgun-sequenced Staphylococcus
species were analysed in 13 longitudinal case studies together with healthy controls. The individual case studies were grouped together with
follow-up samples 1 month and 3 months later (where available) and with or without healthy household controls at the time of initial sampling
and 1 month later for one case study. The x-axis shows the proportional abundance of the top 25 species with a minimum abundance of 0.1%
across the patient samples, which covers 97.85% of all Staphylococcus reads within the longitudinal cohort. The matching species of the healthy
controls are presented at the bottom of Additional file 4: Figure S4 for comparisons. aGPA, active granulomatosis with polyangiitis (GPA); inGPA,
inactive GPA; HC, unrelated healthy controls, HHC, healthy household controls
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analysis, we grouped the active GPA samples and the in-
active GPA samples into one group called “GPA” due to
similarities in their functional analyses (data not shown).
Overall, the HC group showed the lowest abundance of
these ten SEED subsystems, and in most cases, the HHC
had a statistically significant higher abundance of the same
subsystems compared with the DC and/or the HC group.
The GPA patients were significantly enriched for genes in
7/10 SEED subsystems compared with the HC group.
We next combined the ten SEED subsystems and
shotgun species abundance into an annotated heatmap
that provided some insights into the correlation between
the species and SEED subsystems (Fig. 6). Clusters 1 and
2 contain the majority of the healthy control (10/11) and
is dominated by Staphylococcus epidermidis, Dolosigra-
nulum pigrum, Enterobacter cloacae, and to a lesser ex-
tent by two Chryseobacterium species. Cluster 3
contained nearly half of the DC samples (6/13 and
Fig. 5 Statistically significant functional SEED annotation pathway. Shotgun sequences were used for the analysis of SEED functional protein
subsystems. Ten SEED functional protein subsystems were statistically associated with the four sample groups and are shown in Fig. 5. GPA,
granulomatosis with polyangiitis (GPA), DC, disease controls; HC, healthy controls; HHC, healthy household controls
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several GPA samples) and was dominated by Staphylo-
coccus epidermidis and in few samples by Dolosigranu-
lum pigrum and Enterobacter cloacae. Clusters 4 and 5
contained most of the GPA patients samples and all four
of the matched HHC. Multiple Corynebacterium species,
Cutibacterium acnes, and S. aureus and S. epidermidis
(mainly cluster 5) were found in clusters 4 and 5. Ele-
vated SEED functional pathways were detected mostly in
clusters 3, 4 and 5. Elevated SEED functional pathways
in cluster 3 were dominated by genes involved in the
chorismate and methanopterin aromatic function. In
contrast, clusters 4 and 5 were particularly enriched for
Fig. 6 Correlation between metagenomic species and SEED functional protein subsystems. Most abundant shotgun metagenomic species were
correlated with the ten statistically associated SEED functional protein subsystems. The cuth parameter in the dendrogram was set in such a way
that it identified five clusters which are colour coded. The cuth parameter sets the height at which to cut through the dendrogram to define
groups of similar features/samples. A distance metric was generated with R function “vegist” from the VEGAN package using the “bray” method
and Hclust R function from the VEGAN package using the ward. D method was used to cluster the distance matrix. The heatmap was generated
with the Heatplus package from R, version 2.26.0
Wagner et al. Microbiome           (2019) 7:137 Page 10 of 17
genes involved in vitamin B12 and chorismate synthesis.
The HC in clusters 1 and 2 together with DC samples in
the clusters 1, 2 and 3 showed the least elevated abun-
dance of the SEED functional genes.
The impact of disease duration on changes in the
microbiome
Next, we investigated the association between the duration
of the disease for each patient (the time since first diagnosis
of GPA until study enrolment) and dysbiosis of the micro-
biome. For this purpose, we analysed the bacterial 16S data-
set and Staphylococcus shotgun-sequenced dataset using an
unbiased approach based on hierarchical clustering and
heatmap analysis with annotation for disease duration in
months and by patient groups. For the bacterial 16S data-
set, we generated three clusters (coloured green, orange,
and blue) in the heatmap (Additional file 4: Figure S4).
Analysis of beta diversity using a PERMANOVA test re-
vealed that the microbiome composition between the
green, orange and blue clusters identified in the heatmap
(Additional file 4: Figure S4) was statistically different to
each other (P = 0.003, Bonferroni-corrected P value).
Non-parametric Kruskal-Wallis test with Dunn’s mul-
tiple comparison test using the duration of disease in the
different heatmap clusters revealed that the blue cluster
with the most samples from the active GPA group (71%)
had a statistically significant (90% confident interval, P =
0.0561) shorter disease duration (median time of 58.5 ver-
sus 132months) compared with the orange cluster. The
blue and the orange clusters were the clusters with the
most diverse microbiome, whereby the orange cluster is
dominated by Staphylococcus epidermidis. Column statis-
tics (mean, minimum, maximum, SD) for the blue cluster
were 65.71, 5–168, SD 48.16, for the orange cluster were
145.1, 12–552, SD 131, and for the green cluster were
115.8, 5–276, SD 97.4. No statistical differences were iden-
tified between disease duration and Staphylococcus
shotgun-sequenced species (Additional file 5: Figure S5).
Discussion
We undertook a study to investigate the nasal micro-
biota in patients with GPA. Bacterial 16S analysis re-
vealed distinctive heatmap clusters. None of the
bacterial 16S species were associated with any of the pa-
tient groups. This is in contrast to a recent study which
reported a lower abundance of Propionibacterium acnes
and S. epidermidis in patients with GPA, but concurred
that there were no differences in S. aureus abundance
among the different groups [13]. The groups had a small
number of total participants which might have contrib-
uted to non-significant associations. Between-group
comparisons using beta diversity analysis revealed that
the GPA patients grouped together were different to the
healthy controls (HC), suggesting the microbiota of GPA
patients undergoes dysbiosis.
Shotgun metagenomic analysis of Staphylococcus spe-
cies offered a deeper insight into the nasal microbiota. S.
aureus was more abundant in aGPA patients compared
with DC or HC, while S. epidermidis showed an positive
association with HC. PERMANOVA test confirmed dif-
ferences between aGPA versus HC (P = 0.0007) and DC
(P = 0.0023). Moreover, Spearman’s correlation coeffi-
cient showed an association between S. aureus and ac-
tive disease and inactive disease, while S. epidermidis
was associated with HC. Our metagenomic analysis
aligned with our culture data, which also revealed a
higher prevalence of S. aureus in patients with aGPA (8/
12, 66.7%) compared with patients with inGPA (15/44,
34.1%). The lower abundance of S. epidermidis in pa-
tients with GPA was also recently reported by Rhee
et al., in the first study examining the nasal microbiota
in GPA [13]. However, unlike in our study and in con-
trast to one published study [14], they found no associ-
ation with higher abundance of S. aureus in GPA
patients. This discrepancy might be explained by the fact
that the majority (~ 75%) of GPA cases in the study by
Rhee et al. were inactive cases. These results suggest that
during disease activity, a dysbiosis of the nasal micro-
biota is present in patients with GPA.
When we investigated the influence of disease dur-
ation on the microbiome, we identified some differences
in the 16S sequence data between the blue heatmap
cluster, which contained the majority of aGPA patients
(71%) with a shorter median time since diagnosis of
GPA compared with the orange heatmap cluster which
contained only 29% of aGPA patients (29%). All patients
in the blue heatmap cluster with active disease received
immunosuppression (3 rituximab within the last
6 months, 4 steroids and 1 azathioprine), while one of
the active cases in the orange cluster received steroid
monotherapy and the other one had no immunosup-
pressive measure. Both clusters showed a diverse micro-
biome with a trend for a greater abundance for the
Staphylococcus epidermidis and Staphylococcus pseudin-
termedius in the orange cluster compared with the blue
cluster. The statistical test was significant at 90% confi-
dence level and the sample numbers were low; thus, lar-
ger patient groups should be investigated to confirm
whether disease duration, disease activity and the pre-
scribed immunosuppression may influence the nasal
microbiome in GPA patients.
Diverse mechanisms are implicated in the onset of
GPA. S. aureus colonisation has emerged as an inde-
pendent risk factor for disease relapse and higher endo-
nasal activity [6, 7]. Most studies have reported a rate of
S. aureus nasal colonisation which by far exceeds fre-
quencies observed in the general population [15]. The
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mechanism leading to higher colonisation rates are so
far obscure. Low levels of antibodies against S. aureus
antigens were found in patients with GPA [9]. These
findings were related to surface proteins, secreted pro-
teins and superantigens and superantigen-like proteins,
irrespective of the disease state and immunosuppressive
treatment [9].
Our results further indicate that S. aureus and S. epider-
midis seem to have an antagonistic relationship. A similar
antagonistic relationship has been reported in healthy Da-
nish twins [16], though other studies report no effect [17].
A mechanistic basis for S. epidermidis inhibiting S. aureus
is understood; a subset of S. epidermidis strains produce a
serine protease, Esp, which inhibits biofilm formation and
nasal colonisation by S. aureus [18]. Esp is capable of de-
grading essential proteins implicated in adhesion, biofilm
formation, immune and complement evasion, nasal colon-
isation and human receptor proteins of S. aureus includ-
ing fibronectin and fibrinogen [19]. The relationship
between S. aureus and S. epidermidis in patients with
GPA warrants further investigations to decipher factors
related to this observed antagonism.
S. aureus genomic analysis revealed that no clonal
lineage dominated in GPA patients, and there was no evi-
dence of transmission between patients, except in case of
a single GPA patient and a HHC. This is similar to previ-
ous reports using lower-resolution methods [9]. We also
demonstrated in the subset of patients that were repeated
sampled, whole genome sequencing showed that S. aureus
was carried persistently, and the carriers were carrying the
same S. aureus strain over time, independent of active or
inactive disease state. Antibiotic resistance of S. aureus
isolates was measured in a recent study from the
Netherlands [9]. While resistance to penicillin remained
stable over time (72.7%) and was comparable with the
general population, isolates were more resistant to TMP-
SMX (41.4%) and ciprofloxacin (26.7%) over time. This is
likely due to the selective pressure of the use of TMP-
SMX in GPA patients during the last years [9]. While
resistance to penicillin was similar in our cohort, cipro-
floxacin and TMP resistance were only found in a single
isolate from a single inGPA patient (3.4%) only, indicating
that TMP-SMX resistance was rare in our cohort. Only
selected cases with GPA in our clinic receive long-term
TMP-SMX treatment, which may explain the differences
observed in comparison to the Dutch cohort, since long-
time treatment is a mainstay of treating localised GPA in
their daily practise [9, 20]. During the period of sampling,
ten patients with GPA and two with EGPA received
TMP-SMX, of whom seven received TMP-SMX as
Pneumocystis jirovecii prophylaxis, following cyclophos-
phamide or rituximab treatment.
Among the shotgun-sequenced Staphylococcus spp.,
Staphylococcus pseudintermedius was in the top 1%
abundance group and accounted for 13% of all Staphylo-
coccus spp. S. pseudintermedius was detected in the ma-
jority of samples (77.1%), but in 13 samples, it was
detected with a minimum abundance of 1 % (2% to
12.6%). Considering a cutoff of 0.1% abundance, it was
detected in 44% inGPA patients, 41% aGPA patients,
75% HHC, 36% HC and in 46% DC. The presence of S.
pseudintermedius at first sampling and in the following
samples in some patients points towards a persistence in
carriage. S. pseudintermedius is a commensal and oppor-
tunistic pathogen of dogs and cats frequently causing
soft tissue and skin infections [21, 22] and is increasingly
recognised as zoonosis in humans [23]. Most human in-
fections caused by S. pseudintermedius are observed in
dog owners, and most frequently skin and soft tissue in-
fections were reported [22]. A recent report from Spain
reported dog-to-human transmission in two patients
with identical pulsed-field gel electrophoresis patterns,
STs, and antimicrobial resistance phenotypes and geno-
types [24]. Shotgun metagenomic analysis and 16S PCR
highlighted the presence of S. pseudintermedius in all
groups with no significant differences among the groups.
Moreover, the presence of S. pseudintermedius could be
demonstrated by culture in one patient with sequential
samples and in a second patient with single nasal swab;
whole genome sequencing of these revealed that in the
patient with a sequential swabs, this was indeed a case of
persistent carriage [25]. To the best of our knowledge,
this is the first study investigating the nasal microbiome
which emphasises the presence of S. pseudintermedius in
human nostrils. It is unclear to date whether or not S.
pseudintermedius plays a role in GPA disease pathogen-
esis. We found that in most cases with S. pseudinterme-
dius present, the antagonistic relationship between S.
aureus and S. epidermidis was broken, with both species
present at lower levels, suggesting S. pseudintermedius
occupies the same niche.
Visual inspection of the isolate phylogenetic tree with ei-
ther the nasal bacterial 16S profile or shotgun-sequenced
Staphylococcus profile did not show a clear association be-
tween tree structure and nasal microbiota. Bacterial pro-
files were not available for all sequenced isolates; thus,
larger cohorts are warranted to elucidate whether the
nasal microbiota influences the phylogeny of colonising S.
aureus strains.
Functional analysis of the shotgun sequences revealed
319 functional SEED classifications with a minimum
abundance of 0.1% across all samples, and ten of these
showed differences among the patients groups. Among
the ten identified significant functional SEED annotation
pathways, no statistically significant differences were ob-
served between patients with aGPA and inGPA. Thus,
the aGPA and inGPA patients were combined for new
analysis. Three different SEED annotation pathways were
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found to be significantly enriched in subjects with GPA
compared with the DC (the percentage of coenzyme B12
biosynthesis, histidine degradation and COG0523 histi-
dine genes). A further seven SEED annotation pathways
were found to be significantly enriched in GPA patients
compared with the HC (the percentage of chorismate
synthesis, chorismate biosynthesis in plants, common
pathway for synthesis of aromatic compound DAHP
synthase to chorismate, coenzyme B12 biosynthesis, B12
cobalamin HMP, methanopterin aromatic and respira-
tory complex I). Among the significant functional path-
ways, there was a link between patients with GPA and
HHC, further confirming a shared microbiota of individ-
uals living in the same household [26].
Pathway analysis revealed three associations implicated in
chorismate synthesis, which is a key intermediate in the syn-
thesis of tryptophan, phenylalanine and tyrosine [27]. Tryp-
tophan depletion and elevation of metabolites are associated
with T cell hyporesponsiveness [28, 29]. In myeloperoxidase
(MPO)-ANCA vasculitis patients, lower levels of tryptophan
were reported compared with the HC [29]. Patients with
active vasculitis had the lowest levels, while those with
MPO-ANCA vasculitis in remission still had lower levels in
comparison to the HC group [29]. Currently, no data is
available regarding an association between GPA and trypto-
phan metabolism. In our analysis, both GPA and DC
showed enrichment of genes associated with chorismate
synthesis compared with the HC group, which may point
towards the importance of chorismate to generate
tryptophan.
We also found an association with enrichment of
genes involved in the synthesis of vitamin B12 in GPA
and their HHC compared with the DC and HC. Why
there is an enrichment of genes involved in vitamin B12
biosynthesis in GPA patients is not clear. Within the hu-
man gut microbiota, ~ 80% of bacteria have a require-
ment for vitamin B12, but only 20% can produce it [30],
suggesting that there is significant competition for vita-
min B12, which is likely mirrored in the nose. Indeed,
certain gut bacteria have mechanisms for the capture of
vitamin B12 from host proteins [31]. Therefore, within
the nose of GPA patients, vitamin B12 might be in lim-
ited supply, due to the loss of a bacterial producer that
is normally present in the healthy nose, or by changes to
the epithelial environment caused by GPA pathogenesis.
Our findings suggest that differences in the nasal meta-
bolic landscape of GPA patients indicate that distinct meta-
bolic niches become available, which can be occupied by
normally less abundant species, causing the shift of the
taxonomic profile of the GPA patients compared with HC.
Evidence for these changes are present in our heatmap ana-
lysis. Within the GPA clusters 3, 4, and 5, there are distinct
bacterial profiles. There were also differences in the abun-
dances of genes in most of the SEED annotation pathways
between clusters 3, 4, and 5. In particular, the abundance of
genes in the SEED annotation pathway in cluster 3 is lower
than clusters 4 and 5. Cluster 4 is characterised by an in-
creased abundance of Corynebacterium species, a lack of S.
aureus and the greatest abundance of genes in the SEED
annotation pathways. These findings, however, need to be
interpreted with caution and larger studies are warranted to
confirm these results.
Taken together, we observed a higher abundance of S.
aureus during active disease, while S. epidermidis was
the dominant Staphylococcus spp. in HC. Moreover, we
reported for the first time a high abundance of S. pseu-
dintermedius in patients and controls which warrants
further investigation. The rate of antimicrobial resis-
tances in our S. aureus isolates was lower than in previ-
ous studies. In general, the impact of changes in the
nasal microbiota and outcomes (i.e. relapse rates) needs
to be addressed in future longitudinal studies.
Conclusions
In this study, nasal culture results revealed a higher S.
aureus positivity in patients with aGPA. Patients with
GPA, either active or inactive, grouped together when
16S rRNA profiles were analysed. Performance of shot-
gun metagenomic analysis highlighted a dominance of S.
aureus in GPA, while S. epidermidis dominated the
Staphylococcus spp. in HC. SEED functional protein sub-
system analysis revealed an association between bacterial
dysbiosis and elevated abundance of genes in certain
SEED functional groups. We identified S. pseudinterme-
dius in a significant proportion of the study population
which has not been described in such an abundance in
humans before. Further studies investigating the constit-
uents of the nasal microbiota in GPA patients and their
metabolic activity in a longitudinal fashion are necessary
to draw firm conclusions regarding relapse risk among
GPA patients.
Materials and methods
Patient cohort
A total of 84 subjects were enrolled for this study. ENT-
related disease activity was assessed by a structured clin-
ical investigation [32]. All subjects were Caucasian and
were recruited while attending the vasculitis and lupus
clinic at Addenbrooke’s Hospital. Clinical characteristics
of patients and controls are given in Table 1. Written in-
formed consent was obtained from all patients. This
study was conducted in accordance with the ethical
principles stated in the Declaration of Helsinki.
Sample collection, processing, and Staphylococcus spp.
culture
Nasal swabs (MWE Medical Wire, Sigma Dry Swab
Tubed, Corsham, UK) were obtained from both nares
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according to a pre-defined protocol [33]. A detailed de-
scription of swab processing is given in Additional file
11. Antimicrobial susceptibility testing of S. aureus was
performed on a Vitek 2 instrument (card: AST-P634,
bioMérieux, Nürtingen, Germany).
DNA extraction and whole genome amplification
DNA was extracted from nasal swab fluid using the
QIAamp DNA Microbiome Kit. For shotgun sequencing,
REPLI-g Mini kit was used for highly uniform whole gen-
ome amplification (QIAGEN, Hilden, Germany). A detailed
description of the protocol is given in Additional file 11.
Bacterial 16S rRNA gene library preparation and Illumina
MiSeq sequencing
Total DNA was used to perform bacterial 16S PCR reac-
tions using the New England Biolab (NEB) Q5 high-
fidelity polymerase kit. We sequenced the bacterial 16S
variable V1 V2 gene region with Illumina MiSeq 300 pair-
end sequencing technology, which enables 86% full over-
lap sequencing of the 350 bp V1V2 gene region from both
ends. Further details are given in Additional file 12.
Shotgun sequencing and cultured isolate sequencing
All 110 samples were shotgun sequenced across seven
lanes on the Illumina HiSeq platform using version 4
pair end sequencing. Thirty-two S. aureus isolates were
sequenced across one lane on the Illumina HiSeq Plat-
form. Libraries for shotgun sequencing and bacterial iso-
late sequencing were prepared by the Wellcome Sanger
Institute core sequencing facility.
Bioinformatics
Bacterial 16S rRNA marker gene analysis
Bacterial 16S rRNA sequences were processed according
to the mothur MiSeq SOP. For further details, see the
online Additional file 12.
Oligotyping and species identification
Oligotyping was used for clustering the high-quality fil-
tered FASTA sequences from the mothur pipeline [34].
The node representative sequence of each oligotype
(OTP) was used for species profiling using the ARB ana-
lysis - A Software Environment for Sequence Data (ver-
sion 5.5-org-9167) [35]. We followed a highly stringent
in-house pipeline to remove environmental and labora-
tory contaminants. A detailed description of oligotyping
and species identification is given in Additional file 12.
Shotgun sequence analysis
The number for raw reads from the shotgun sequencing
across the 110 samples was between 7.1 million and 23.5
million reads per samples. High-quality reads were used
for contigs and scaffolds generation. Scaffolds were
searched using BLASTX search against the NCBI non-
redundant nucleotide database and taxonomically anno-
tated. Staphylococcus species were used for further
analysis in this study. A detailed description of bioinfor-
matics is given in Additional file 12.
Staphylococcus isolates sequence analysis
Genomic DNA was extracted from S. aureus isolates, li-
braries prepared and 150-bp paired-end sequences de-
termined on an Illumina HiSeq2000 as previously
described [36]. Sequence data were assembled using an
in-house pipeline [37]. A brief description is given in
Additional file 12. The presence of S. aureus virulence
factors and antibiotic resistance genes were identified
using BLAST against the assemblies. For phylogenetic
analyses, sequence reads were mapped to a relevant ref-
erence genome (ST398 (strain S0385, accession number
AM990992) for the overall tree, see Additional file 1:
Figure S1) using SMALT (http://www.sanger.ac.uk/sci-
ence/tools/smalt-0) using the default settings to identify
SNPs. For the ST398 phylogeny, the large block of ST8
recombination present in ST398 (S0385 genomic loca-
tions: 12252 to 135180) was also removed from the
ST398 alignment. SNPs located in mobile genetic ele-
ments were removed, and a maximum likelihood tree
was created using RAxML using the default settings and
100 bootstrap replicates [38].
Functional analysis of shotgun metagenomic sequences
For functional analysis of shotgun metagenomic sequence
data, we used the functional classification systems of
MEGAN using SEED protein subsystem classification. De-
tailed description are giving in Additional file 12.
Heatmap analysis
Diamond BLASTX search together with MEGAN ana-
lysis of SPAde contigs identified a total of 2891 hits at
the species level. Four hundred species with a minimum
abundance of 0.01% were used for further analysis. This
represent a total of 93.42% MEGAN hits at the species
level. Those 400 species were used for heatmap gener-
ation together with metadata for the 10 statistically sig-
nificant SEED functional protein subsystem.
A distance metric was generated with R function
“vegist” from the VEGAN package using the “bray”
method and Hclust R function from the VEGAN pack-
age using the ward. D method was used to cluster the
distance matrix. The heatmap was generated with the
Heatplus package from R, version 2.26.0.
For easier representation of species on the heatmap,
only species with a minimum relative abundance of 2%
in at least two samples were used. This cutoff identified
22 of the most abundant species shown on the heatmap.
The “cuth” parameter was set to 2.1 which generated
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five coloured clusters on the hierarchal clustered den-
drogram and in the annotation plots. The cuth param-
eter sets the height at which to cut through the
dendrogram to define groups of similar features/samples.
We used four sample groups and all ten statistically sig-
nificant SEED functional protein subsystems for
annotation.
Statistical and visual data analysis
Pattern of beta diversity of bacterial communities, i.e.
how the microbiome varies between the different sample
groups, was statistically assessed using PERMANOVA.
The PERMANOVA test generates a P value and a F stat-
istic and was performed using the statistical package
PAST version 3.09 [39]. Additional information about
the PERMANOVA test is given in Additional file 12.
Unbiased hierarchical clustering with heatmap gener-
ation was generated using the R package “Heatplus” [40].
Stack bar chart presented next to the heatmaps was gener-
ated in Apple Keynote version 6.6.2. The proportional
abundance of species used for the stack bar charts was cal-
culated in Microsoft Excel for Mac, version 15.41.
The rank-based indirect gradient analysis “NMDS”
was used for the visualisation of taxonomic differences
(beta diversity differences) between the different groups.
Additional information about NMDS is given in Add-
itional file 12. In addition to NMDS, we also used CA,
an indirect gradient analysis based on a multivariate stat-
istical technique similar to principal component analysis
that provides a means of displaying or summarising a set
of data in a two-dimensional graphical form.
Spearman’s rho coefficient analyses were performed
with PAST3 [39] to identify patterns of association of
bacterial OTP species with particular sample groups.
Scatter plot presentation of samples and non-parametric
Kruskal-Wallis test with Dunn’s multiple comparison
test was done in GraphPad Prism 6 for Mac OS X, ver-
sion 6.0h.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s40168-019-0753-z.
Additional file 1: Figure S1. 31 cultured Staphylococcus isolates were
sequenced and their assembled genomes were used for phylogenetic
tree construction. a. Bacterial 16S marker gene sequenced species were
matched with cultured S. aureus isolates in their phylogenetic tree. The
top 22 species with a minimum abundance of 0.1% were used for the
stack bar chart presentation. The top 22 species represented 98.91% of all
reads. Please note: a bacterial 16S profile was not available from all
samples from which an isolate was sequenced. b. Shotgun sequenced
Staphylococcus species were matched with cultured S. aureus isolates in
their phylogenetic tree. The top 28 taxa with a minimum abundance of
0.1% were used for the stack bar chart presentation. The top 28 taxa
represented 97.25% of all reads. Please note: A Staphylococcus profile was
not available from all samples from which an isolate was sequenced.
(PDF 8765 kb)
Additional file 2: Figure S2. NMDS analysis of bacterial 16S marker
gene sequenced species. a. NMDS plot reveals that healthy controls (HC)
form a cluster separating them from inactive [green ellipse] and active
GPA patients [orange ellipse]. The two disease controls (EGPA) are within
the inGPA and aGPA clusters. The overall cluster separation is not
statistically different (PERMANOVA test: P value > 0.05). b. The inGPA and
aGPA samples were grouped into one cluster [GPA cluster, orange
ellipse]. PERMANOVA test between the three groups revealed that
samples from the combined GPA patients are statistically different from
the healthy control (HC) samples (PERMANOVA P value = 0.039, F value =
1.739). (PDF 155 kb)
Additional file 3: Figure S3. Taxonomic annotation of longitudinal
case studies using bacterial 16S marker gene sequenced species. Bacterial
diversity in six patients with follow up sampling one month (n = 6) and 3
months later (n = 1) is shown. In two case studies, household controls at
the initial sampling time point (n = 2) and one month later (n = 1) were
also available. For comparisons, seven healthy controls are shown at the
bottom of the figure. The abundance of the top 27 species with a
minimum 0.1% contribution in samples from longitudinal case studies
with matching species from healthy controls are shown on the x axis.
(PDF 629 kb)
Additional file 4: Figure S4. Heatmap analysis with annotation for
disease duration in months and active GPA and inactive GPA disease
stage using top 28 species with a minimum abundance of 0.5% in at
least one sample in the bacterial 16S rRNA dataset. (PDF 75 kb)
Additional file 5: Figure S5. Heatmap analysis with annotation for
disease duration in months and active GPA, inactive GPA, and disease
control using top 18 Staphylococcus species with a minimum abundance of
0.5% in at least one sample in the shotgun sequenced dataset. (PDF 83 kb)
Additional file 6: Table S1. Antimicrobial susceptibility testing of S.
aureus isolates. (DOCX 18 kb)
Additional file 7: Table S2. S. aureus isolates and relevant metadata.
(XLSX 13 kb)
Additional file 8: Table S3. Relative abundance of S. aureus in the
bacterial 16S dataset and in the shot gun metagenomic dataset. (DOCX 16 kb)
Additional file 9: Table S4. Positive MEGAN hits for shot gun
sequenced Staphylococcus species. (XLSX 10 kb)
Additional file 10: Table S5. 319 SEED functional protein subsystem
with minimum abundance of 0.01% in base line samples. (XLSX 181 kb)
Additional file 11. Supplementary Material and Method (DOCX 92 kb)
Additional file 12. Bioinformatics Analysis (DOCX 45 kb)
Abbreviations
AB: Antibiotic; aGPA: Active GPA; ANCA: Anti-neutrophil cytoplasm antibody;
CA: Correspondence analysis; DC: Disease control; DNA: Deoxyribose nucleic
acid; EGPA: Eosinophilic granulomatosis with polyangiitis; ENT: Ear, nose and
throat; GPA: Granulomatosis with polyangiitis; HC: Healthy control;
HHC: Healthy household control; inGPA: Inactive GPA; MALDI-TOF: Matrix-
assisted laser desorption/ionisation–time-of-flight mass spectrometry;
MLST: Multilocus sequence type; MPO: Myeloperoxidase; MRSA: Methicillin-
resistant Staphylococcus aureus; NMDS: Non-metric multidimensional scaling;
OTP: Oligotype; PCR: Polymerase chain reaction; PERMANOVA: Permutational
multivariate analysis of variance; RNA: Ribonucleic acid; SNP: Single-
nucleotide polymorphism; ST: Sequence type; TMP-SMX: Trimethoprim-
sulfamethoxazole; WGS: Whole genome sequencing
Acknowledgements
We thank the Wellcome Sanger Institute library construction team, the
sequencing and core informatics teams. AK was supported by the ERA-EDTA
with a long-term fellowship (12 months) from August 2014 to August 2015.
EMH is supported by a UK Research and Innovation (UKRI) Fellowship: MR/
S00291X/1.
Authors’ contributions
DRWJ and AK developed the study concept and design. JW, EMH, BB, JL and
AK performed all laboratory work. MDPM, PG and AK collected samples and
clinical data. GM, MAH, JP, SJP were involved in the final study design. JW,
Wagner et al. Microbiome           (2019) 7:137 Page 15 of 17
EMH and AK analysed the data. JW, AK and EMH were major contributors in
writing the manuscript with critical input from MAH, JP, SJP and DRWJ. All
authors read and approved the final manuscript.
Funding
Supported by the NIHR Cambridge Comprehensive Biomedical Research
Centre Immunity, Infection and Inflammation theme.
Availability of data and materials
European Nucleotide Archive (ENA) study accession: ERP016546.
Ethics approval and consent to participate
The study was approved by the NRES Committee East of England –
Cambridge Central. All participants approved to participate, and written
informed consent was obtained.
Consent for publication
Not applicable.
Competing interests
Gert Mayer received speaking and consulting fees from Böhringer Ingelheim,
AbbVie, TEWA, Amgen, Novo Nordisk, Eli Lilly, Vifor and Otsuka. Mark A.
Holmes received consultancy fees from Polypharmakos Ltd. and the
Wellcome Trust. Sharon J. Peacock and Julian Parkhill received consulting fee
from Next Gen Diagnostics. David R.W. Jayne received consulting fees from
Astra-Zeneca, Böhringer Ingelheim, ChemoCentryx, GSK, Roche and Vifor. An-
dreas Kronbichler received speaking fees from Chugai, Miltenyi Biotech and
TerumoBCT.
Author details
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton,
Cambridgeshire CB10 1SA, UK. 2Department of Medicine, University of
Cambridge, Box 157, Addenbrooke’s Hospital, Hills Road, Cambridge CB2
0QQ, UK. 3Department of Public Health and Primary Care, University of
Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge
CB1 8RN, UK. 4West Suffolk Hospital, Hardwick Lane, Bury St. Edmunds,
Suffolk, UK. 5Department of Internal Medicine IV (Nephrology and
Hypertension), Medical University Innsbruck, Innsbruck, Austria. 6Vasculitis
and Lupus Clinic, Box 57, Addenbrooke’s Hospital, Hills Road, Cambridge CB2
0QQ, UK. 7Department of Veterinary Medicine, University of Cambridge,
Cambridge, UK. 8London School of Hygiene and Tropical Medicine, WC1E
7HT, London, UK.
Received: 9 November 2018 Accepted: 24 September 2019
References
1. Furuta S, Jayne DR. Antineutrophil cytoplasm antibody-associated vasculitis:
recent developments. Kidney Int. 2013;84(2):244–9.
2. Yang J, Ge H, Poulton CJ, Hogan SL, Hu Y, Jones BE, Henderson CD, McInnis
EA, Pendergraft WF 3rd, Jennette JC, et al. Histone modification signature at
myeloperoxidase and proteinase 3 in patients with anti-neutrophil
cytoplasmic autoantibody-associated vasculitis. Clin Epigenetics. 2016;8:85.
3. Lane SE, Watts RA, Bentham G, Innes NJ, Scott DG. Are environmental
factors important in primary systemic vasculitis? A case-control study.
Arthritis Rheum. 2003;48(3):814–23.
4. Beaudreuil S, Lasfargues G, Laueriere L, El Ghoul Z, Fourquet F, Longuet C,
Halimi JM, Nivet H, Buchler M. Occupational exposure in ANCA-positive
patients: a case-control study. Kidney Int. 2005;67(5):1961–6.
5. Hogan SL, Satterly KK, Dooley MA, Nachman PH, Jennette JC, Falk RJ,
Glomerular disease collaborative N. Silica exposure in anti-neutrophil
cytoplasmic autoantibody-associated glomerulonephritis and lupus
nephritis. J Am Soc Nephrol. 2001;12(1):134–42.
6. Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg
CG. Association of chronic nasal carriage of Staphylococcus aureus and
higher relapse rates in Wegener granulomatosis. Ann Intern Med. 1994;
120(1):12–7.
7. Laudien M, Gadola SD, Podschun R, Hedderich J, Paulsen J, Reinhold-Keller
E, Csernok E, Ambrosch P, Hellmich B, Moosig F, et al. Nasal carriage of
Staphylococcus aureus and endonasal activity in Wegener s granulomatosis
as compared to rheumatoid arthritis and chronic Rhinosinusitis with nasal
polyps. Clin Exp Rheumatol. 2010;28(1 Suppl 57):51–5.
8. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim-
sulfamethoxazole (co-trimoxazole) for the prevention of relapses of
Wegener's granulomatosis. Dutch co-Trimoxazole Wegener study group. N
Engl J Med. 1996;335(1):16–20.
9. Glasner C, van Timmeren MM, Stobernack T, Omansen TF, Raangs EC,
Rossen JW, de Goffau MC, Arends JP, Kampinga GA, Koedijk DG, et al. Low
anti-staphylococcal IgG responses in granulomatosis with polyangiitis
patients despite long-term Staphylococcus aureus exposure. Sci Rep. 2015;5:
8188.
10. Coll F, Harrison EM, Toleman MS, Reuter S, Raven KE, Blane B, Palmer B,
Kappeler ARM, Brown NM, Torok ME et al: Longitudinal genomic
surveillance of MRSA in the UK reveals transmission patterns in hospitals
and the community. Sci Transl Med 2017, 9(413):doi: https://doi.org/10.
1126/scitranslmed.aak9745.
11. Popa ER, Stegeman CA, Abdulahad WH, van der Meer B, Arends J, Manson
WM, Bos NA, Kallenberg CG, Tervaert JW. Staphylococcal toxic-shock-
syndrome-toxin-1 as a risk factor for disease relapse in Wegener's
granulomatosis. Rheumatology. 2007;46(6):1029–33.
12. de Goffau MC, Lager S, Salter SJ, Wagner J, Kronbichler A, Charnock-Jones
DS, Peacock SJ, Smith GCS, Parkhill J. Recognizing the reagent microbiome.
Nat Microbiol. 2018;3(8):851–3.
13. Rhee RL, Sreih AG, Najem CE, Grayson PC, Zhao C, Bittinger K, Collman RG,
Merkel PA. Characterisation of the nasal microbiota in granulomatosis with
polyangiitis. Ann Rheum Dis. 2018;77(10):1448–53.
14. Lamprecht P, Fischer N, Huang J, Burkhardt L, Lütgehetmann M, Arndt F,
Rolfs I, Kerstein A, Iking-Konert C, Laudien M. Changes in the composition of
the upper respiratory tract microbial community in granulomatosis with
polyangiitis. J Autoimmun. 2019;97:29–39.
15. Kronbichler A, Kerschbaum J, Mayer G. The influence and role of microbial
factors in autoimmune kidney diseases: a systematic review. J Immunol Res.
2015;2015:858027.
16. Liu CM, Price LB, Hungate BA, Abraham AG, Larsen LA, Christensen K,
Stegger M, Skov R, Andersen PS. Staphylococcus aureus and the ecology of
the nasal microbiome. Sci Adv. 2015;1(5):e1400216.
17. Yan M, Pamp SJ, Fukuyama J, Hwang PH, Cho DY, Holmes S, Relman DA.
Nasal microenvironments and interspecific interactions influence nasal
microbiota complexity and S. aureus carriage. Cell Host Microbe. 2013;14(6):
631–40.
18. Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, Agata T, Mizunoe Y.
Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm
formation and nasal colonization. Nature. 2010;465(7296):346–9.
19. Sugimoto S, Iwamoto T, Takada K, Okuda K, Tajima A, Iwase T, Mizunoe Y.
Staphylococcus epidermidis Esp degrades specific proteins associated with
Staphylococcus aureus biofilm formation and host-pathogen interaction. J
Bacteriol. 2013;195(8):1645–55.
20. Cohen Tervaert JW. Trimethoprim-sulfamethoxazole and antineutrophil
cytoplasmic antibodies-associated vasculitis. Curr Opin Rheumatol. 2018;
30(4):388–94.
21. Moodley A, Damborg P, Nielsen SS. Antimicrobial resistance in methicillin
susceptible and methicillin resistant Staphylococcus pseudintermedius of
canine origin: literature review from 1980 to 2013. Vet Microbiol. 2014;
171(3–4):337–41.
22. Somayaji R, Priyantha MA, Rubin JE, Church D. Human infections due to
Staphylococcus pseudintermedius, an emerging zoonosis of canine origin:
report of 24 cases. Diagn Microbiol Infect Dis. 2016;85(4):471–6.
23. Yarbrough ML, Lainhart W, Burnham CA. Epidemiology, Clinical
characteristics, and antimicrobial susceptibility profiles of human clinical
isolates of Staphylococcus intermedius group. J Clin Microbiol. 2018;56(3).
https://doi.org/10.1128/JCM.01788-17.
24. Lozano C, Rezusta A, Ferrer I, Perez-Laguna V, Zarazaga M, Ruiz-Ripa L,
Revillo MJ, Torres C. Staphylococcus pseudintermedius human infection
cases in Spain: dog-to-human transmission. Vector Borne Zoonotic Dis.
2017;17(4):268–70.
25. Kronbichler A, Blane B, Holmes MA, Wagner J, Parkhill J, Peacock SJ, Jayne
DRW, Harrison EM. Nasal carriage of Staphylococcus pseudintermedius in
patients with granulomatosis with polyangiitis. Rheumatology. 2019;58(3):
548–50.
26. Mosites E, Sammons M, Otiang E, Eng A, Noecker C, Manor O, Hilton S,
Thumbi SM, Onyango C, Garland-Lewis G, et al. Microbiome sharing
Wagner et al. Microbiome           (2019) 7:137 Page 16 of 17
between children, livestock and household surfaces in western Kenya. PLoS
One. 2017;12(2):e0171017.
27. Crawford IP. Synthesis of tryptophan from chorismate: comparative aspects.
Methods Enzymol. 1987;142:293–300.
28. Moffett JR, Namboodiri MA. Tryptophan and the immune response.
Immunol Cell Biol. 2003;81(4):247–65.
29. Chavele KM, Shukla D, Keteepe-Arachi T, Seidel JA, Fuchs D, Pusey CD,
Salama AD. Regulation of myeloperoxidase-specific T cell responses during
disease remission in antineutrophil cytoplasmic antibody-associated
vasculitis: the role of Treg cells and tryptophan degradation. Arthritis
Rheum. 2010;62(5):1539–48.
30. Rowley CA, Kendall MM. To B12 or not to B12: five questions on the role of
cobalamin in host-microbial interactions. PLoS Pathog. 2019;15(1):e1007479.
31. Wexler AG, Schofield WB, Degnan PH, Folta-Stogniew E, Barry NA, Goodman
AL. Human gut Bacteroides capture vitamin B12 via cell surface-exposed
lipoproteins. Elife. 2018, Sep 18;7. https://doi.org/10.7554/eLife.37138.
32. Martinez Del Pero M, Rasmussen N, Chaudhry A, Jani P, Jayne D. Structured
clinical assessment of the ear, nose and throat in patients with
granulomatosis with polyangiitis (Wegener's). European archives of oto-
rhino-laryngology : official journal of the European Federation of Oto-Rhino-
Laryngological Societies. 2013;270(1):345–54.
33. Miller JM, Miller SA. A guide to specimen management in clinical
microbiology. 3rd ed; 2017.
34. Eren AM, Morrison HG, Lescault PJ, Reveillaud J, Vineis JH, Sogin ML.
Minimum entropy decomposition: unsupervised oligotyping for sensitive
partitioning of high-throughput marker gene sequences. ISME J. 2015;9(4):
968–79.
35. Ludwig W, Strunk O, Westram R, Richter L, Meier H, Yadhukumar, Buchner A,
Lai T, Steppi S, Jobb G, et al. ARB: a software environment for sequence
data. Nucleic Acids Res. 2004;32(4):1363–71.
36. Reuter S, Ellington MJ, Cartwright EJ, Koser CU, Torok ME, Gouliouris T,
Harris SR, Brown NM, Holden MT, Quail M, et al. Rapid bacterial whole-
genome sequencing to enhance diagnostic and public health microbiology.
JAMA Intern Med. 2013;173(15):1397–404.
37. Page AJ, De Silva N, Hunt M, Quail MA, Parkhill J, Harris SR, Otto TD, Keane
JA. Robust high-throughput prokaryote de novo assembly and
improvement pipeline for Illumina data. Microbial genomics. 2016;2(8):
e000083.
38. Stamatakis A, Ludwig T, Meier H. RAxML-III: a fast program for maximum
likelihood-based inference of large phylogenetic trees. Bioinformatics. 2005;
21(4):456–63.
39. Hammer Ø, Harper DAT, Ryan PD. PAST: paleontological statistics sofware
package for education and data analysis. Palaeontol Electron. 2001;4:1–9.
40. Ploner A: Heatplus: Heatmaps with row and/or column covariates and
colored clusters. 2015(R package version 2.22.0).
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Wagner et al. Microbiome           (2019) 7:137 Page 17 of 17
